Navigation Links
GeNO LLC Announces New Patent for Nitric Oxide Delivery System
Date:6/9/2011

COCOA, Fla., June 9, 2011 /PRNewswire/ -- GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced it has been awarded a new patent for its NITROSYL™ (Inhaled Nitric Oxide) Systems.  U.S. Patent No. 7,947,227, GeNO's seventh patent, concerns a method of providing a therapeutic amount of nitric oxide (NO) to a mammal in a manner that converts nitrogen dioxide (NO2) to nitric oxide (NO).  The NO2 can originate from either a gas bottle or a liquid source. This new patent is set to expire in August 2029.

"It is unusual for a drug already in Phase II clinical trials to have the core technology protected by patents that still have at least 18 years of life," said GeNO LLC Founder and President David Fine.   "This patent further solidifies the strong intellectual property foundation of the company and is an important milestone for the development of our novel NITROSYL Systems."

GeNO's NITROSYL™ Systems aim to add a valuable option for clinicians treating a range of serious pulmonary diseases with inhaled nitric oxide. GeNO's plans for both in-hospital and ambulatory inhaled nitric oxide systems would help address the cost, complexity and lack of portability of current treatment regimens, and would potentially reach a much larger group of patients.

Additional study details can be found on http://clinicaltrials.gov/ -- ClinicalTrials.gov Identifiers NCT01092559 and NCT01265888.  

ABOUT GENO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, includi
'/>"/>

SOURCE GeNO LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... VIEW, Calif., Nov. 11 MAP Pharmaceuticals, Inc. (Nasdaq: ... the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, ... City. , A live webcast of the presentation will ... website at http://www.mappharma.com . A replay will also be ...
... Nov. 10 Inc. magazine has ranked West Physics ... of the fastest-growing private companies in the U.S. West Physics ... 100 Health Companies and No. 32 on the list of the ... Consulting posted three-year revenue growth of 327.8% to make the list. ...
Cached Medicine Technology:West Physics Consulting Makes the 2009 Inc. 5000 List 2
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... a review published in the April issue of ... Feinstein Institute for Medical Research, says it,s time to ... approach to treating sepsis, which kills millions worldwide ... occurs when molecules released into the bloodstream to fight ... Inflammation is necessary for maintaining good health without ...
(Date:4/17/2014)... 17, 2014U.S. military personnel who served in Iraq ... traumatic brain injury (TBI) were compared to military ... medical reasons. Differences in measures of overall disability, ... after injury are reported in an article in ... from Mary Ann Liebert, Inc., publishers. The article ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... Patient undergoing multiple tests to diagnose and investigate ... which seemed to be promoted //by advanced imaging ... (ESC) has recommended that an inter-disciplinary collaboration of ... non-invasive diagnosis could ensure effective diagnosis of heart ...
... of Medical Research (MIMR) have developed a new machine, ... babies constantly. ,Although it was the ... monitor continuously, the fluctuating BP and brain oxygen levels ... the Monash Institute of Medical Research (MIMR) are carrying ...
... University of Bristol have recommended that knee cartilage injuries ... any signs of osteoarthritis progression. ,'The ... only about 12 months and this is the first ... ,The study, 'Maturation of tissue engineered cartilage implanted ...
... Santosh Baniya whose parents were diagnosed with HIV was ... the disease//. ,Santosh Baniya succumbed to his ... Ahmedabad last week. ,The boy’s parents, both ... ago. Investigations have suggested that Santosh Baniya feared surviving ...
... conducted by Stephanie Chiuve it was found that a healthy ... ,U.S. researchers stated that patients suffering from blood pressure and ... ,It was discussed that middle aged men can reduce their ... and change their drinking and smoking habits. ,But ...
... New Zealand Winegrowers are affected by the type 3 virus ... of grapevines//. ,But most of the winegrowers have ... are free from the virus. New Zealand Winegrowers science and ... is being done to understand the virus spread and ongoing ...
Cached Medicine News:Health News:Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend 2Health News:Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend 3Health News:Preterm Babies Benefited from a New NI Spectroscopy 2Health News:Engineered Tissue Implants benefited Knee Injured patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: